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Using sixteen different primers based on the cDNA sequence of the human casein kinase II-a subunit, different fragments of this gene were amplified 
by PCR from human genomic DNA. The sizes of these fragments were identical to amplified cDNA, which suggests the existence of an intronless 
genomic gene. The amplification was carried out on whole blood genomic DNA from three different individuals. The total sequence of the amplified 
casein kinase II-a gene showed more than 99% homology to the cDNA. The gene contains a noninterrupted open reading frame, as expected for 
the homolog cDNA. Although the gene sequence is complete, four point mutations were found. Since there are no interruptions of the open reading 
frame, this intronless gene might be expressed. 
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1. INTRODUCTION 
Casein kinase II (CKII) is a serineithreonine protein 
kinase widely distributed among species and it is inde- 
pendent of any known physiological regulators such as, 
CAMP Ca2’/calmodulin and phospholipids. The gene 
structure, expression regulation and enzymatic activity 
of CKII have been widely studied particularly in rela- 
tion to its involvement in cell growth (reviewed in [l]). 
Although the physiological role of CKII is still unclear 
it has been shown to phosphorylate a wide range of 
different substrates, in vivo and in vitro, which are in- 
volved in key regulatory processes. Among these sub- 
strates are several oncogenes and antioncogenes [24], 
transcription factors [5,6] and enzymes that participate 
in DNA and RNA synthesis [7,8]. 
CKII is an heterodimer composed of two very similar 
but distinct catalytic subunits (ala’) and two regulatory 
subunits ds). The cDNA [9-121 and gene [13,14] se- 
quences for the three subunits have been characterized 
in several species. The cDNAs for human CKII, a, a’ 
and p subunits [15-171 have been described as well as 
the gene sequence for the p subunit [14]. Mapping of 
human chromosomes through in situ hybridization 
have localized the human CKII-a DNA sequence to two 
loci [ 181, indicating the presence of at least two different 
genes. 
In this report, we present the sequence of an intron- 
less gene for human CKII-a which shows no interrup- 
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tions in an open reading frame. There are four differ- 
ences in the amino acid sequences of the cDNA and the 
gene, although none occur in conserved regions for pro- 
tein kinase, catalytic and/or ATP binding system [19]. 
In contrast to the (pseudo)gene recently described by 
Wirkner et al. [20], which contained a stop codon corre- 
sponding to amino acid position 296, the findings pre- 
sented here indicate that this intronless gene may code 
for a physiologically relevant CKII. 
2. MATERIALS AND METHODS 
Oligonucleotides based on the human cDNA sequence of CKII-a 
were synthesized with an Applied Biosystems DNA synthesizer. A 
BumHI restriction site was added to each 5’ end in order to subclone 
the PCR amplified fragments into the M 13mp 18 vector. The primers 
(P) were homologous to the cDNA sequence at the indicated positions: 
PO: -691-50; Pl: O/17; P3: +112/+129; P5: +318/+334; P7: +568/584; 
P9: +819/+835; Pll: +879/895; P13: +1033/+1049; Pl4: +1159/+1141; 
P15: +1211/+1193. Primers, P2, P4, P6, P8, PlO and P12, correspond 
to primers P3, P5, P7, P9, Pll and P13, respectively, but in the oppo- 
site directions (Fig. 1). 
2.1. DNA isolation from whole blood 
Ten ml of whole blood were collected from three different individu- 
als, in tubes containing 500 ~1 of 0.5 M EDTA as an anticoagulant. 
After centrifugation at 2500 rpm for 15 min, the plasma was discarded 
and solution A (0.32 M sucrose, 10 mM Tris buffer pH 7.5, S mM 
MgCl,, 1% Triton X-100) was added to a final volume of 25 ml. After 
mixing gently the tubes were kept on ice for 30 min, and centrifuged 
as before. After centrifugation, 21 ml of the supematant was dis- 
carded, and the tubes were refilled with solution A, to a final volume 
of 25 ml. After incubating the tubes on ice for 20 min, they were 
centrifuged at 2500 rpm for 15 min, after which time the supematant 
was discarded. The pellet was resuspended in 1.5 ml of solution B (10 
mM Tris, pH 7.5, 400 mM NaCl, 2 mM EDTA) supplemented with 
0.7% SDS and 500 pg of proteinase K. After overnight incubation at 
37°C. SO0 ~1 of 5 M NaCl were added by vortexing for 15 s. The tubes 
were centrifuged, the supernatant recovered and the DNA was precip- 
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Fig. 1. Primer localization in the human CKII-a subunit cDNA sequence. The localization of all the primers used is indicated. 
itated by adding 2 ~01s. of ethanol (95%). The DNA was collected by 
centrifugation, resuspended in TE buffer and quantified. 
2.2. PCR amplification 
PCR amplification was carried out using Taq DNA polymerase 
(Promega Co.) with the following program: step 1, 95°C - 5 min (1 
cycle); step 2, 95°C - 1 min; qOC - 1 min; 72’C - 1 min (28 cycles); 
step 3, 72°C - 10 min (1 cycle). 
2.3. DNA sequencing 
After amplification, the DNA fragments were digested with BarnHI 
restriction endonuclease and subcloned into a M13mp18 vector. The 
sequencing was performed using the dideoxy chain termination 
method [21] using Sequenase version 2.0 (US Biochemicals) and [“S]tx- 
dATP (New England Nuclear). All of the fragments were amplified 
twice to check possible Taq DNA polymerase rrors. Amino acid and 
nucleotide analysis of the sequences obtained were performed with the 
PCgene software. 
2.4. Southern blot analysis 
Human genome DNA (5 pg) was digested with PvuII restriction 
endonuclease, fractionated on 1% agarose gels and hybridized as de- 
scribed [22]. DNA fragments were transferred onto Nytran nylon 
filters and hybridized with 32P-labeled probes. DNA probes were the 
products of PCR amplifications of the CKII-a subunit gene, prepared 
using different pairs of primers. These probes contained the 5’ third, 
the middle and the 3’ third of the gene. After amplification the DNA 
fragments were purified through electrophoresis on 3% NuSieve-aga- 
rose gels, followed by electroelution onto DEAE membrane as de- 
scribed [22]. 
3. RESULTS 
3.1, DNA amplification of the CKII-a subunit gene 
Sixteen different oligonucleotides based on the cDNA 
sequence of the human CKII-a subunit were used to 
amplify different segments of the genomic homolog 
gene. The primers were combined in pairs in different 
ways. Fig. 2 shows the analysis of some of the fragments 
obtained (lanes l-7). All of them correspond closely to 
the expected sizes for an intronless gene. None of the 
fragments were found to be larger than the correspond- 
ing cDNA amplified products. Also the amplification of 
the whole gene with primers PO and P15 (lane 8) shows 
a 1.3 kb fragment which is identical to the size of the 
cDNA. 
3.2. Genomic projile of the CKII-a subunit by Southern 
blotting 
In order to analyze the entire structure of the gene, 
four different probes containing segments of the CKII-a 
gene were utilized in a Southern blot analysis. These 
probes corresponded to DNA fragments amplified with 
primers PO/P4; P5/P8; P9/P15 and the whole gene ampli- 
fied with primers PO/P15 The published cDNA for 
St12345678 
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Fig. 2. DNA amplification of the human CKII-a gene: 300 ng of DNA were submitted to PCR amplification with different pairs of oligonucleotide 
primers. The primers used and the size of the DNA fragments obtained are indicated. Lane 1 = PO/P4 (403 bp); lane 2 = P3/P6 (476 bp); lane 3 
= P5/P6 (266 bp); lane 4 = P5/P8 (518 bp); lane 5 = P7/10 (327 bp); lane 6 = P9/12 (230 bp); lane 7 = P13/15 (178 bp); lane 8 = PO/P15 (1.3 kb). 
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Fig. 3. Southern blot analysis of CKII-a genes. Genomic DNA was 
digested with PvuII, electrophoresed and blotted to a nylon membrane 
as described under Materials and Methods. The hybridization was 
carried out with four different probes as indicated. The membrane was 
exposed to X-Omat-AR Kodak film for 3 days. Lane 1 = PO/PI 5: lane 
2 = PO/P4; lane 3 = P5/P8; lane 4 = IWP15; and lane 5 = CKII-a’ 
The amplified DNA fragments, from the three indi- 
viduals, were subcloned into the M13mpl8 vector and 
sequenced. The resulting sequences (Fig. 4) show a 99% 
homology to the CKII-a cDNA. No stop codon muta- 
tions were found inside the coding sequence. The initia- 
tion and termination codons were located as expected 
from the cDNA. No deletion or insertion mutations 
were found. However, four nucleotide point mutations 
that resulted in four amino acid differences, appeared 
within the coding region at amino acid positions 128, 
256,287 and 351 (Fig. 5). These mutations would result 
in changes of Leu to Phe, Asp to Gly, Ser to Arg, and 
Met to Val, respectively, of which only the Met to Val 
change is conservative. 
3’ end. 4. DISCUSSION 
CKII-cr subunit has two PvuII restriction sites in the 
coding sequence, located at positions + 120 and + 1153, 
and one site in the 5’ noncoding region at position -70 
(the cDNA for CKII-a’ subunit has no PvuII restriction 
sites within its coding region). The expected hybridizing 
bands for an intronless CKII-a gene are 1.03 kb and 190 
bp. Of these, only the 1.03 kb band would be detected 
under the electrophoretic onditions used. 
To perform the Southern analysis, human genomic 
DNA was digested with PvuII restriction endonuclease, 
electrophoresed, transferred to a nylon membrane, and 
hybridized with the four described probes, as shown in 
Materials and Methods. As shown in Fig. 3, lane 1, 
there are three main hybridizing bands of 12.5 kb, 7.8 
kb and 1 .O kb, when the probe (PO/P15) representing the 
entire cDNA sequence is used. When the hybridization 
is carried out with probe PO/P4 only two bands ap- 
peared (lane 2). In the case of probe P9/P15 (lane 4) two 
bands are shown, but the larger fragment (7.8 kb) is 
different in size from the one in lane 2 (12.5 kb). As these 
two probes carry the 5’ and 3’ coding sequences, respec- 
tively, the results shown indicate that these two hy- 
bridizing bands correspond to the beginning (12.5 kb) 
and the end (7.8 kb) of a CKII-a subunit gene with 
intron(s). 
The fact that the gene shows an approximate size of 
20 kb, suggests that it has introns. The small band (1.0 
kb) hybridizes with all of the probes, indicating that this 
is the one that carries the intronless gene. 
A similar Southern analysis was done using as the 
probe a fragment from the CKII-a’ subunit gene. In this 
case (lane 5) only one hybridizing band of 6.1 kb was 
obtained, which is different in size from the CKII-a 
ones. Since this probe contains the 3’ third of the CKII- 
01’ gene, this result suggests that there is only one CKII- 
01’ subunit gene. 
3.3. Sequencing analysis of DNA fragments 
We have described a human CKII-a gene that does 
not contain introns in its structure. The size of the DNA 
fragments obtained after PCR amplification suggested 
the presence of an intronless gene. In the human 
genome, two CKII-a genes have been mapped by in situ 
hybridization and assigned to two different loci: 
llp15.5-~15.4 and 20~13 [18]. We have established 
through Southern blot analysis the approximate size of 
these two genes, showing that one of them has the same 
size of the cDNA (1.2 kb). The second one has an ap- 
proximate size of 20 kb. The DNA sequence of the gene 
described showed a 99% homology to the cDNA. Two 
nucleotide changes which would not lead to changes in 
amino acid composition were found. Four other nucleo- 
tide differences occurred in the corresponding cDNA 
coding region, which would lead to amino acid differ- 
ences at positions 128 (Leu to Phe), 256 (Asp to Gly), 
287 (Ser to Arg), and 351 (Met to Val). However, none 
of these amino acids are conserved in CKII-a subunits 
[23] and/or protein kinases [19], and all of them are 
located in sequences not involved in the catalytic or 
ATP binding domains [ 191. 
While this manuscript was in preparation, Wirkner et 
al. [20] described a (pseudo)gene from a human placenta 
genomic library. This (pseudo)gene contained a stop 
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gagcagaggggagacggccgccgccctggccgcttccaccacagtttgaagaaaacaggtctgaa 
CCAMATCMGTCCAG 
acaaggtcttacccccagctgcttctgaacacagtgactgccagatctccaaacatcaagtccag . . . . . . . . . . 
s~~~c"~~T~~~~~~~~~~~~~*~~~~~~~~~~ 
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Fig. 4. Comparison of an intronless CKII-a gene DNA sequence with the human cDNA. Sequence of the PCR amplified DNA fragments. All 
of the fragments were amplified at least twice, purified as described under Materials and Methods and sequenced. The nucleotide identity with 
the cDNA sequence is indicated by dots. Nucleotide changes that would result in a different amino acid indicated by *. Nucleotides changes that 
would not lead into amino acid differences are indicated by dashes. 
codon in the position corresponding to amino acid 296 
of the cDNA open reading frame. The important differ- 
ence between the sequence reported by Wirkner et al. 
and that shown in this work is that our gene does not 
possess a stop codon in the coding region and thus 
would not lead to a truncated protein. It should be 
noted that we have sequenced DNA fragments from 
three different individuals, in order to avoid Taq DNA 
polymerase rrors and specific polymorphisms. In these 
sequences the results clearly indicate the presence of the 
same codon (GAG) at position 296. This discrepancy 
might obviously be explained by the existence of a mu- 
tation in the individual from which the placenta gene 
was obtained by Wirkner et al. [20]. It will be interesting 
to examine the expression of CKII-a in different human 
tissues in order to determine if in fact this gene is ex- 
pressed. It is noteworthy that the hypothetical 
(pseudo)gene possesses a promoter-like region up- 
stream from the potential initiation codon which in- 
cludes two TATA boxes and one CAAT box [20]. In 
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Fig. 5. Comparison of the resulted amino acid sequences from the intronless gene and the cDNA for the human CKII-a subunit. The amino acid 
sequences from the cDNA and the intronless gene are shown. The four amino acid changes are indicated by *. 
conclusion, the facts that a stop codon is not present in 
the gene of the individuals analyzed in this report, and 
that the gene is 99% identical to the cDNA, suggest that 
this gene might code for a physiologically relevant 
CKII-a. 
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